Acid overcomes drug resistance in myeloma and significantly increases the anti-myeloma effects of both arsenic trioxide and melphalan in vitro and in vivo.

被引：5
|
作者：
Campbell, RA
Chen, HM
Zhu, DC
Santos, JC
Bonavida, B
Pang, S
Said, J
Berenson, JR
机构：
[1] Inst Myeloma & Bone Canc Res, W Hollywood, CA USA
[2] Univ Calif Los Angeles, Sch Med, MIMG, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2470.2470
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2470
引用
收藏
页码：678A / 678A
页数：1
相关论文
共 24 条
  • [21] A novel human Fc-optimized ICAM-1/CD54 antibody (MSH-TP15e) with potent anti-myeloma activity in vitro and in vivo.
    Peipp, Matthias
    Gramatzki, Martin
    Burger, Renate
    Klausz, Katja
    Kellner, Christian
    Guenther, Andreas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Targeting MEK1/2 Signaling Cascade by AS703026, a Novel Selective MEK1/2 Inhibitor, Induces Pleiotropic Anti-Myeloma Activity in Vitro and In Vivo.
    Tai, Yu-Tzu
    Kim, Kihyun
    Li, Xian-Feng
    Fulciniti, Mariateresa
    Song, Weihua
    Nahar, Sabikun
    Burger, Peter
    Rumizen, Mathew J.
    Podar, Klaus
    Chauhan, Dharminder
    Hideshima, Teru
    Schlossman, Robert L.
    Munshi, Nikhil C.
    Richardson, Paul
    Clark, Ann
    Ogden, Janet
    Andreas, Goutopoulos
    Rastelli, Luca
    Anderson, Kenneth C.
    [J]. BLOOD, 2009, 114 (22) : 1480 - 1480
  • [23] Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo
    Savvidou, Ioanna
    Khong, Tiffany
    Whish, Sophie
    Carmichael, Irena
    Sepehrizadeh, Tara
    Mithraprabhu, Sridurga
    Horrigan, Stephen K.
    de Veer, Michael
    Spencer, Andrew
    [J]. CANCERS, 2022, 14 (03)
  • [24] In vitro and in vivo molecular profiling of multiple myeloma (MM) cell interactions with bone marrow (BM) microenvironment: Insight into the role of novel anti-MM agents in counteracting BM-mediated drug-resistance in MM.
    Mitsiades, CS
    Mitsiades, N
    McMullan, CJ
    Poulaki, V
    Shringarpure, R
    Hideshima, T
    Chauhan, D
    Munshi, NC
    Joseph, M
    Libermann, TA
    Anderson, KC
    [J]. BLOOD, 2003, 102 (11) : 441A - 441A
123